Immunogenicity, Effectiveness, and Safety of Trivalent Inactivated Influenza Split Vaccine in Patients with Inflammatory Joint Diseases Receiving Modern Antirheumatic Therapy

Immunogenicity, Effectiveness, and Safety of Trivalent Inactivated Influenza Split Vaccine in Patients with Inflammatory Joint Diseases Receiving Modern Antirheumatic Therapy

According to the currently available data from large cohort studies, patients with immuno-inflammatory rheumatic diseases (IIRDs) are at increased risk of infectious complications, including influenza, compared to the general population. Vaccinations are a critical component of their care. However,...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser:	M. M. Baranova, N. V. Muravyeva, B. S. Belov, M. E. Diatroptov, D. V. Bukhanova
Format:	Artikel
Sprache:	Russian
Veröffentlicht:	LLC "Publishing House OKI" 2024-06-01
Schriftenreihe:	Антибиотики и Химиотерапия
Schlagworte:	influenza rheumatoid arthritis ankylosing spondylitis psoriatic arthritis vaccination efficacy immunogenicity safety
Online Zugang:	https://www.antibiotics-chemotherapy.ru/jour/article/view/1129

Ähnliche Einträge

Immunogenicity, efficacy and safety of the three-valent inactivated influenza split vaccine in patients with ankylosing spondylitis and psoriatic arthritis
von: M. M. Baranova, et al.
Veröffentlicht: (2024-06-01)

Efficacy, safety and immunogenicity of a trivalent inactivated split influenza vaccine in patients with rheumatic diseases
von: D. V. Bukhanova, et al.
Veröffentlicht: (2018-07-01)

Do individuals with inflammatory arthritis receive minimally adequate treatment for incident depression and anxiety: A population-based study
von: Alyssa Howren, et al.
Veröffentlicht: (2025-01-01)

Gait characteristics associated with the foot and ankle in inflammatory arthritis: a systematic review and meta‐analysis
von: Matthew Carroll, et al.
Veröffentlicht: (2015-01-01)

Persistence and costs with subcutaneous TNF-alpha inhibitors in immune-mediated rheumatic disease stratified by treatment line
von: Svedbom A, et al.
Veröffentlicht: (2017-01-01)

Rheumatoid arthritis and spondyloarthritis prevalence in four European countries - a comparative study
von: Zlatković-Švenda Mirjana, et al.
Veröffentlicht: (2022-01-01)

Association Between Nursing Support Levels and Effectiveness of Golimumab in the Management of Patients with Rheumatologic Diseases
von: Hermine Leroi, et al.
Veröffentlicht: (2020-05-01)

Comorbidities in inflammatory joint and spine diseases in XXI century
von: I Z Gaydukova, et al.
Veröffentlicht: (2018-12-01)

Persistence to subcutaneous biological agents in Hungarian patients treated for inflammatory arthritis
von: Takacs P, et al.
Veröffentlicht: (2019-01-01)

Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort study
von: Joshua L. Lee, et al.
Veröffentlicht: (2018-08-01)

The frequency and structure of comorbid infections in patients with spondyloarthritis (preliminary own data)
von: M. M. Baranova, et al.
Veröffentlicht: (2021-03-01)

Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
von: M. Rossini, et al.
Veröffentlicht: (2015-03-01)

Hypogonadism in men with inflammatory joint diseases: Frequency and clinical characteristics
von: Taras S. Panevin, et al.
Veröffentlicht: (2024-06-01)

The data project: a shared approach between stakeholders of the healthcare system in definition of a therapeutic algorithm for inflammatory arthritis
von: I. Pantano, et al.
Veröffentlicht: (2023-03-01)

Significance of Interleukin (IL)-4 and IL-13 in Inflammatory Arthritis
von: Milena Iwaszko, et al.
Veröffentlicht: (2021-11-01)

Ankylosing spondylitis and psoriatic arthritis: clinical and economic consequences of the use of etanercept
von: Viola Sacchi, et al.
Veröffentlicht: (2010-06-01)

Circulating miRNA Correlates with Lipid Profile and Disease Activity in Psoriatic Arthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis Patients
von: Krzysztof Bonek, et al.
Veröffentlicht: (2022-04-01)

Impact of tumor necrosis factor inhibitors and methotrexate on diabetes mellitus among patients with inflammatory arthritis
von: Santhi Mantravadi, et al.
Veröffentlicht: (2020-09-01)

Use of antidepressants and benzodiazepine-related hypnotics before and after initiation of TNF-α inhibitors or non-biological systemic treatment in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis
von: Philip Brenner, et al.
Veröffentlicht: (2020-02-01)

Evaluation of the possibility of axial psoriatic arthritis patients meet classification criteria for axial spondyloarthritis and ankylosing spondylitis
von: E. E. Gubar, et al.
Veröffentlicht: (2023-08-01)

Nod-like receptors in inflammatory arthritis
von: Sahib Singh Madahar, et al.
Veröffentlicht: (2024-02-01)

Inflammatory arthritis and eye diseases: a Mendelian randomization study
von: Xinlin Nie, et al.
Veröffentlicht: (2023-10-01)

Pooled safety results across phase 3 randomized trials of intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
von: M. Elaine Husni, et al.
Veröffentlicht: (2022-03-01)

A Prospective Study to Evaluate the Impact of Golimumab Therapy on Work Productivity and Activity, and Quality of Life in Patients With Rheumatoid Arthritis, Psoriasis Arthritis and Axial Spondyloarthritis in a Real Life Setting in AUSTRIA. The GO-ACTIVE Study
von: Christian Dejaco, et al.
Veröffentlicht: (2022-06-01)

SAFETY AND EFFECTIVENESS OF TRI VALENT INACTIVATED SPLIT VIRION INFLUENZA VACCINE IN PATIENTS WITH RHEUMATOID DISORD ERS
von: D. V. Bukhanova, et al.
Veröffentlicht: (2018-07-01)

The association of relapsing polychondritis and spondylarthritis – three case reports
von: Eleonora Alina Dragomir-Lica, et al.
Veröffentlicht: (2023-09-01)

Characteristics of patients with psoriatic arthritis in Korea: focusing on axial involvement
von: Hanna Park, et al.
Veröffentlicht: (2024-01-01)

Treatment persistence of subcutaneous TNF inhibitors among Australian patients with immune-mediated rheumatic disease (IMRD)
von: Acar M, et al.
Veröffentlicht: (2018-11-01)

The interchangeability of original tumor necrosis factor- α inhibitors and biosimilars in rheumatology: experience in replacing original infliximab with Flammagis for ankylosing spondylitis
von: Yu. V. Muravyev, et al.
Veröffentlicht: (2020-05-01)

Adherence to biological therapies in patients with chronic inflammatory arthropathies
von: Noemí Martínez-López de Castro, et al.
Veröffentlicht: (2019-07-01)

Unraveling immune cell heterogeneity in autoimmune arthritis: insights from single-cell RNA sequencing
von: Sotaro Nakajima, et al.
Veröffentlicht: (2024-10-01)

Management of tuberculosis risk, screening and preventive therapy in patients with chronic autoimmune arthritis undergoing biotechnological and targeted immunosuppressive agents
von: Andrea Picchianti-Diamanti, et al.
Veröffentlicht: (2025-02-01)

The troubling liaison between cancer and metabolic syndrome in chronic inflammatory rheumatic diseases
von: Giovanni Cioffi, et al.
Veröffentlicht: (2021-03-01)

Diagnosis of spondyloarthritis: should we need new criteria?
von: I. Z. Gaidukova, et al.
Veröffentlicht: (2015-03-01)

Prevalence of spondyloarthritis and its subtypes - are they really comparable?
von: Zlatković-Švenda Mirjana I., et al.
Veröffentlicht: (2019-01-01)

Significance of asymptomatic hyperuricemia in ankylosing spondylitis
von: R. M. Balabanova, et al.
Veröffentlicht: (2021-06-01)

Inflammatory back pain in psoriatic arthritis is significantly more responsive to corticosteroids compared to back pain in ankylosing spondylitis: a prospective, open-labelled, controlled pilot study
von: Muhammad Haroon, et al.
Veröffentlicht: (2018-04-01)

Newly diagnosed seropositive rheumatoid arthritis in a 52-year-old man superimposed on long-standing ankylosing spondylitis during secukinumab treatment
von: Jaroslaw Nowakowski, et al.
Veröffentlicht: (2023-10-01)

Coexistence of rheumatoid arthritis and ankylosing spondylitis
von: Tacjana Anna Barczyńska, et al.
Veröffentlicht: (2015-12-01)

Features of medical and social expertise in ankylosing spondylitis and psoriatic arthritis
von: T. V. Dubinina, et al.
Veröffentlicht: (2023-02-01)